Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 18, 2021

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

HypertensionObesity

Interventions

DRUG

Neuropeptide Y

intra-arterial infusion of neuropeptide Y

Trial Locations (1)

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER